WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'6701 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 12'6371 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 428  418  408  397  386  280  223  158 
Births
Surviving infants
Pop. less than 5 years 39  38  38  37  35  33  43  28 
Pop. less than 15 years 100  98  96  95  94  114  106  72 
Female 15-49 years 109  108  106  105  103  69  47  34 

Number of reported cases

(Click for retrospective incidence data for Maldives)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  20 
Mumps
ChartChart
  17  14 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Maldives)
Vaccine year result method % card seen                                                
BCG 2008  99  DHS   89  99*  99*  99  99*  99*  99  99 
DTP1 2008  99  DHS   89  99*  99*  99  99  99  99 
DTP3 2008  98  DHS   89  99  99*  99  99  99*  98  94 
DTP4         
IPV1          99  99* 
HepB_BD          99*  99  99*  99  62 
HepB3 2008  97  DHS   89  99  99*  99  99  99  96 
Hib3          99  99*  99  99* 
JapEnc         
MCV1          99  99  99*  99  98  99  96 
MCV2          99  99*  97  99  99 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2008  97  DHS   89  99  99  99*  99*  99  98  94 
Rota1         
RotaC         
RCV1          99  99*  97  99  99 
TT2plus 2000  43  MICS     99*  99*  99*  99*  99  98  89 
PAB         
VAD1          99  99  99*  96  91  98 
YFV          99* 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Maldives)
BCG
  99  99  99  99  99  99  99 
DTP1
  99  99  99  99  99  98  97  22 
DTP3
  99  99  99  99  99  98  94 
HepB3
  99  99  99  99  99  96 
HepB_BD
 
Hib3
  99  99  99  58 
IPV1
  99  82 
MCV1
  99  99  99  99  98  99  96 
MCV2
  99  99  97  99  99 
PCV3
 
Pol3
  99  99  99  99  99  98  94 
RCV1
  99  99  97  99  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes
Influenza Hajj and other travellers
IPV 6 months; Yes
Measles 9 months; Yes
MenACWY >= 15 years; Yes pilgrims
MenACWY-135 conj >= 15 years; Yes pilgrims
MMR 18 months; Yes
MR From April 2017
OPV 2, 4, 6 months; and 15 years old pilgrims
Td 15 years; +1, +6 months; +1, +1 year; Yes
VitaminA 9, 18, 24, 30, 36, 42 months; Yes
YF Yes +Y15 travellers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2016-2020  2016-2020  2009-2013  2009-2013  2009-2013  2009-2013   
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20  20  20  20  20 

System performance

Total Nº districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 20  20  20  21  20  20  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  105  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 20  20  20  21  20  20  20 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  105  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 71  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.